We'll reply to your email within 24 hours

Mitochondrial-derived peptide for metabolic and cellular energy research.
SKU: MOTSC-10MG
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded by the mitochondrial genome, discovered in 2015 by Dr. Changhan Lee's laboratory. This peptide represents a paradigm shift in understanding mitochondrial function—demonstrating that mitochondria actively regulate metabolism through encoded signaling peptides.
MOTS-c is the first mitochondrial-derived peptide (MDP) to reach clinical investigation, with ongoing studies exploring its potential in metabolic diseases and aging.
MOTS-c exemplifies a new class of mitochondrial regulators:
| Mechanism | Action | Metabolic Effect |
|---|---|---|
| AMPK Activation | Energy sensor engagement | Enhanced glucose uptake |
| Nuclear Translocation | Stress-responsive gene regulation | Adaptive metabolism |
| Folate-AICAR Pathway | De novo purine synthesis inhibition | Metabolic flexibility |
| Exercise Response | Upregulated by physical activity | Endurance enhancement |
MOTS-c levels decline with age, correlating with decreased metabolic flexibility and physical capacity.
MOTS-c is being studied for its potential effects on:
Clinical trials are investigating MOTS-c in obesity and fatty liver disease (NCT03998514).
FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. This product is intended for laboratory and research purposes only. Not for human or animal consumption.
Based on 0 reviews
Be the first to review MOTS-c